How to deal with common adverse reactions of sotoraxib
Sotorasib (AMG510, Sotorasib) has shown good efficacy as a targeted therapy for KRAS G12C mutation-related cancers (non-small cell lung cancer), but it may also cause some adverse reactions. Common side effects include gastrointestinal reactions, skin reactions, abnormal liver function, etc.
Gastrointestinal reactions are a common problem that patients encounter during treatment. The most common symptoms include nausea, vomiting, loss of appetite, and diarrhea. Although common, these symptoms are usually mild or moderate and can be alleviated by changing eating habits, such as avoiding greasy, spicy and other irritating foods. If the symptoms are mild, the patient can continue taking the medication at the prescribed dose. For more severe gastrointestinal discomfort, your doctor may consider adjusting the dose or suspending treatment until symptoms improve.
Skin reactions are also common adverse reactions to sotorasiib, particularly rash, itching, and dryness. If symptoms are mild, patients can use topical medications to relieve discomfort or use antihistamines as recommended by their doctor. If the rash is severe, especially if it is accompanied by other systemic symptoms, the patient should contact the doctor promptly, and the dosage of the drug may need to be reduced or the use of the drug may be suspended until symptoms improve.
Abnormal liver function is a common side effect of sotoraxib. Patients need to regularly monitor liver function, especially the levels of liver enzymes (such asAST, ALT) during treatment. If elevated liver enzymes are detected, doctors may make appropriate treatment adjustments based on the patient's condition, such as reducing drug dosage, suspending treatment, or switching to other treatment options. Severe hepatic impairment usually requires discontinuation of the drug and further treatment.
In addition, sotoracib may cause some rare but serious side effects, such as difficulty breathing, chest pain, and extreme fatigue. For these symptoms, patients should seek medical attention immediately so that timely measures can be taken.
Reference materials:https://www.lumakras.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)